Flexion Therapeutics

-$0.02 (-0.22%) Today
$0.00 (0.00%) As of 11:24 PM UTC after-hours

Why Robinhood?

You can watch FLXN and buy or sell other stocks, options, and ETFs commission-free!

About FLXN

Flexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners.

CEO
Michael D. Clayman, MD
Employees
—
Headquarters
Burlington, Massachusetts
Founded
2007

FLXN Key Statistics

Market cap
458.73M
Price-Earnings ratio
—
Dividend yield
—
Average volume
3.03M
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$13.66
52 Week low
$4.30

FLXN Earnings

-$0.60
-$0.40
-$0.20
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure